Table 1 Average plasma total and LDL cholesterol concentrations during follow-up
Baseline characteristic | Plasma total cholesterol (mmol/l) | Plasma LDL cholesterol (mmol/l) | ||||
|---|---|---|---|---|---|---|
| Â | Simvastatin | Placebo | Difference* | Simvastatin | Placebo | Difference* |
Sex | Â | Â | Â | Â | Â | Â |
Male | 4.1 | 5.3 | -1.2 | 2.2 | 3.2 | -1.0 |
Female | 4.6 | 5.8 | -1.2 | 2.5 | 3.4 | -0.9 |
Age (years) | Â | Â | Â | Â | Â | Â |
<65 | 4.3 | 5.4 | -1.1 | 2.4 | 3.2 | -0.9 |
≥65 <70 | 4.1 | 5.4 | -1.3 | 2.2 | 3.3 | -1.0 |
≥70 | 4.2 | 5.5 | -1.3 | 2.2 | 3.3 | -1.1 |
Total cholesterol (mmol/L) | Â | Â | Â | Â | Â | Â |
<5.0 | 3.5 | 4.6 | -1.1 | 1.8 | 2.6 | -0.9 |
≥5.0 <6.0 | 4.0 | 5.2 | -1.2 | 2.1 | 3.1 | -1.0 |
≥6.0 | 4.8 | 6.0 | -1.2 | 2.7 | 3.7 | -1.0 |
LDL cholesterol (mmol/L) | Â | Â | Â | Â | Â | Â |
<3.0 | 3.7 | 4.9 | -1.1 | 1.8 | 2.7 | -0.9 |
≥3.0 <3.5 | 4.1 | 5.3 | -1.2 | 2.2 | 3.2 | -1.0 |
≥3.5 | 4.7 | 5.9 | -1.2 | 2.7 | 3.7 | -1.0 |
ALL PATIENTS | 4.2 | 5.4 | -1.2 | 2.3 | 3.3 | -1.0 |